Intuitive Surgical, Inc. (ISRG) Given Consensus Rating of “Buy” by Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned a consensus rating of “Buy” from the twenty brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating on the company. The average 12-month price target among analysts that have covered the stock in the last year is $581.31.

A number of research firms have recently commented on ISRG. Cantor Fitzgerald set a $620.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research report on Thursday, April 4th. Zacks Investment Research cut Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, March 12th. BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 23rd. Deutsche Bank began coverage on Intuitive Surgical in a research report on Monday, April 1st. They issued a “buy” rating and a $630.00 price objective for the company. Finally, ValuEngine upgraded Intuitive Surgical from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd.

ISRG stock traded down $6.10 during trading on Monday, hitting $513.01. 25,002 shares of the company traded hands, compared to its average volume of 1,005,152. The stock has a market cap of $59.77 billion, a P/E ratio of 54.10, a P/E/G ratio of 4.53 and a beta of 1.10. Intuitive Surgical has a 1 year low of $430.24 and a 1 year high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 EPS for the quarter, missing the Zacks’ consensus estimate of $2.70 by ($0.09). The business had revenue of $974.00 million during the quarter, compared to analysts’ expectations of $975.27 million. Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The firm’s quarterly revenue was up 14.9% compared to the same quarter last year. During the same quarter last year, the firm earned $2.44 earnings per share. Research analysts anticipate that Intuitive Surgical will post 9.4 EPS for the current year.

In other news, COO Salvatore Brogna sold 2,090 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $551.79, for a total value of $1,153,241.10. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Curet Myriam sold 1,410 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 20th. The stock was sold at an average price of $546.56, for a total value of $770,649.60. Following the completion of the sale, the executive vice president now directly owns 2,417 shares in the company, valued at $1,321,035.52. The disclosure for this sale can be found here. Insiders sold 45,740 shares of company stock worth $23,918,554 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund boosted its stake in Intuitive Surgical by 31,963.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 14,679,377 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 14,633,595 shares during the last quarter. BlackRock Inc. boosted its stake in Intuitive Surgical by 7.3% during the fourth quarter. BlackRock Inc. now owns 8,327,815 shares of the medical equipment provider’s stock worth $3,988,358,000 after buying an additional 569,388 shares during the last quarter. Vanguard Group Inc boosted its stake in Intuitive Surgical by 0.4% during the third quarter. Vanguard Group Inc now owns 8,313,421 shares of the medical equipment provider’s stock worth $4,771,903,000 after buying an additional 29,260 shares during the last quarter. Morgan Stanley boosted its stake in Intuitive Surgical by 119.5% during the third quarter. Morgan Stanley now owns 2,856,195 shares of the medical equipment provider’s stock worth $1,639,456,000 after buying an additional 1,554,896 shares during the last quarter. Finally, Jennison Associates LLC boosted its stake in Intuitive Surgical by 40.5% during the fourth quarter. Jennison Associates LLC now owns 1,949,684 shares of the medical equipment provider’s stock worth $933,743,000 after buying an additional 562,441 shares during the last quarter. 84.88% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Recommended Story: What is a Derivative?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.